Navigation Links
ProCertus BioPharm secures $2.3M in financing

Madison, Wis. - A Madison company that is developing drugs to protect cancer patients from common side effects of chemotherapy and radiotherapy has closed on a Series A Preferred Stock financing led by Venture Investors of Madison.

ProCertus BioPharm, an oncology-based pharmaceutical company, will ......

Full article >>> ious stages, when potential corporate partners were interested in its technology and any human data associated with it, Fahl said the new executives will be important in managing the infusion of venture capital and in identifying large pharmaceutical partners to help develop the technology and bring it to market.

Venture Investors traditionally has looked for investments in companies with......

Full article >>> five clinical studies to establish safety and efficacy for each.

Of the three drug candidates, Fahl said OralX is the only one that would face a competitive product on the market, and that particular therapy has limited efficacy.

Lab results

The inventions associated the company's intellectual property are derived from research done in Fahls laboratory. In additi......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 05/11/07


Related biology technology :

1. Glossary for The BioPharm Guide to Fermentation and Cell Culture
2. TrafficCast secures $2M from Phenomenelle Angels, NEW Capital Fund
3. Perscitus Biosciences secures $250K Commerce loan
4. Mirus Bio secures $900K grant to develop research tool
5. BioSystem Development secures angel funding
6. TrafficCast secures $1 million line of credit
7. Medical College secures $9.7M research grant
8. Wausau start up secures $560K for GPS maps
9. Platypus Technologies secures $450K SBIR grant
10. Congresswoman Baldwin secures Federal Funds for UW-Rock County
11. 2006: A great biotech financing year, unless you were going public!
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/14/2017)... (PRWEB) , ... September 14, ... ... announces the launch of its CliniControl™ (CC) product portfolio, clinically-relevant starting and ... clinical translation of human Mesenchymal Stem/Stromal Cell (hMSC)-based therapies. The CliniControl product ...
(Date:9/14/2017)... (PRWEB) , ... September 14, 2017 , ... AIM Global, ... Medical Tracking Systems Inc. has won the 2017 Case Study Competition for AIDC. ... which provide benefits that decrease risk” and push the adoption of automated data collection ...
(Date:9/12/2017)... Boston, MA (PRWEB) , ... September 12, 2017 ... ... Physiology Analytics (PPA) and highly scalable cloud-based platform for ambulatory patient monitoring and ... Disruptive Innovations to Advance Clinical Trials conference in Boston. , Launched in ...
(Date:9/12/2017)... ... September 12, 2017 , ... Soybean researchers seeking funding from ... "pre-proposal” by October 15, prior to completing a full grant application. , “The ... our priorities, and to encourage researchers to further develop ones that might need ...
Breaking Biology Technology:
(Date:6/23/2017)... and ITHACA, N.Y. , ... and Cornell University, a leader in dairy research, today ... bioinformatics designed to help reduce the chances that the ... the onset of this dairy project, Cornell University has ... for Sequencing the Food Supply Chain, a food safety ...
(Date:5/6/2017)... , May 5, 2017 RAM ... announced a new breakthrough in biometric authentication based ... quantum mechanical properties to perform biometric authentication. These new ... semiconductor material created by Ram Group and its ... entertainment, transportation, supply chains and security. Ram Group ...
(Date:4/13/2017)... UBM,s Advanced Design and Manufacturing event in ... and evolving technology through its 3D Printing and Smart ... the expo portion of the event and feature a ... on trending topics within 3D printing and smart manufacturing. ... will take place June 13-15, 2017 at the Jacob K. ...
Breaking Biology News(10 mins):